TB: What is big pharma doing?
This article was originally published in Scrip
Executive Summary
The Access to Medicine Index has analyzed where big pharma companies are focusing their R&D efforts to tackle TB. The Index found that big pharma is focusing mainly on developing new vaccines and drugs, and that its efforts are concentrated on drug-resistant strains of TB.